As of Oct 02
| +8.53 / +7.23%|
The 13 analysts offering 12-month price forecasts for Incyte Corp have a median target of 126.00, with a high estimate of 145.00 and a low estimate of 94.00. The median estimate represents a -0.36% decrease from the last price of 126.46.
The current consensus among 15 polled investment analysts is to Buy stock in Incyte Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.